Switch to:

Beam Therapeutics Short-Term Debt

: $1.66 Mil (As of Mar. 2020)
View and export this data going back to 2020. Start your Free Trial

Beam Therapeutics's Short-Term Debt for the quarter that ended in Mar. 2020 was $1.66 Mil.

Beam Therapeutics's quarterly Short-Term Debt increased from Sep. 2019 ($0.80 Mil) to Dec. 2019 ($1.30 Mil) and increased from Dec. 2019 ($1.30 Mil) to Mar. 2020 ($1.66 Mil).

Beam Therapeutics's annual Short-Term Debt stayed the same from Dec. 2017 ($0.00 Mil) to Dec. 2018 ($0.00 Mil) but then increased from Dec. 2018 ($0.00 Mil) to Dec. 2019 ($1.30 Mil).


Beam Therapeutics Short-Term Debt Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
Short-Term Debt 0.00 0.00 1.30

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Short-Term Debt Premium Member Only Premium Member Only 0.00 0.00 0.80 1.30 1.66

Beam Therapeutics Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Beam Therapeutics Short-Term Debt Related Terms


Beam Therapeutics Short-Term Debt Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)